Enlibio,Your biological research partner

Wuhan Enlibio Biotech Co.,Ltd
2008-2024
Biological abstract
文章附图

AbstractThe mosquito-borne Zika virus is an emerging pathogen from the Flavivirus genus for which there are no approved ...

文章附图

AbstractA plague vaccine with a fusion cassette of YscF, F1, and LcrV encoding genes in an adenovirus-5 vector (rAd5-YFV...

文章附图

AbstractRed blood cells (RBCs) stressed by high temperature are similar to senescent or damaged RBCs in pathological con...

文章附图

AbstractAlthough immune checkpoint inhibitors (ICIs) can induce durable responses in non-small-cell lung cancer (NSCLC) ...

文章附图

AbstractDespite the frequent use of ionising radiation (IR) in therapy and diagnostics and the unavoidable exposure to e...

文章附图

AbstractPneumonia caused by the intracellular bacterium Rhodococcus equi is an important cause of disease and death in i...

文章附图

AbstractComplications associated with urinary bladder augmentation provide the motivation to delineate alternative bladd...

文章附图

AbstractMycobacterium tuberculosis (Mtb) exposure drives antibody responses, but whether patients with active tuberculos...

文章附图

AbstractCAR-T transfer, recently well-developed immunotherapy, has offered substantial benefit to more and more patients...

文章附图

AbstractThe introduction of the CTLA-4 recombinant fusion protein has demonstrated therapeutic effects by selectively mo...

Prev
...
89 90 91 92 93
...
Next
mail: info@enlibio.com   mail: sale@enlibio.com     Tel:+86-027-87610298
mail: alex@enlibio.com   mail: order@enlibio.com  Tel:+86-027-87610297
Add:B105,Building C1,R&D Building,Zone B,C,D,Wuhan National Bio-Industry Base,No.666 Gaoxin Avenue,East Lake New Technology Development Zone, Wuhan, China